Version May 2024
| Patients with active disease |
| Every 3 to 6 months |
| ROS including fever, fatigue, weight loss, visual disturbance, dyspnea, cough, palpitations, abdominal pain, numbness, tingling, lightheadedness, syncope |
| PE including skin examination, palpation of lymph nodes, lung exam |
| Laboratory tests based on sites of disease activity and medications |
| Spirometry, diffusing capacity |
| Every 12 months |
| CBC and differential |
| Creatinine |
| Calcium |
| AST, ALT, Alkaline phosphatase |
| 25 hydroxy vitamin D |
| 1,25 dihydroxy vitamin D |
| EKG; sooner if palpitations, lightheadedness, syncope |
| Ophthalmologic exam (slit lamp, fundoscopic, tonometric), if on hydrocychloroquine |
| Chest radiograph |
| As indicated by symptoms or other tests |
| HRCT |
| Echocardiogram |
| Holter monitoring |
| Urinalysis |
| TSH (association of thyroid autoimmunity and sarcoidosis) |
| Bone density when glucocorticoid therapy initiated and then every 3 years |
| MRI with gadolinium if neurologic symptoms (unless diabetic) |
| Patients with inactive disease for 2 or more years |
| Every 12 to 18 months |
| ROS including fever, fatigue, weight loss, visual disturbance, dyspnea, cough, palpitations, abdominal pain, numbness, tingling, lightheadedness, syncope |
| PE including skin examination, palpation of lymph nodes, lung exam |
| Spirometry, diffusing capacity |
| CBC and differential |
| Creatinine |
| Calcium |
| Liver enzymes |
| 1,25 dihydroxy vitamin D |
| EKG; sooner if palpitations, lightheadedness, syncope |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
